Analysis | Metabolite Name | Measured Value | Units | Treatment:Group 7 |
---|---|---|---|---|
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 7468 | Peak area | Homocysteine Treated- 48 hours - Group 7 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 9750 | Peak area | Homocysteine Treated- 48 hours - Group 7 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 10178 | Peak area | Homocysteine Treated- 12 hours - Group 5 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 10875 | Peak area | Homocysteine Treated- 48 hours - Group 7 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 12299 | Peak area | Homocysteine Treated- 24 hours - Group 6 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 12974 | Peak area | Homocysteine Treated- 48 hours - Group 7 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 13286 | Peak area | Homocysteine Treated- 24 hours - Group 6 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 13694 | Peak area | Homocysteine Treated-2 hours - Group 2 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 13817 | Peak area | Homocysteine Treated-2 hours - Group 2 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 14080 | Peak area | Homocysteine Treated- 24 hours - Group 6 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 14802 | Peak area | Homocysteine Treated- 12 hours - Group 5 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 16795 | Peak area | Homocysteine Treated- 4 hours - Group 3 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 17153 | Peak area | Homocysteine Treated-2 hours - Group 2 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 17184 | Peak area | Homocysteine Treated- 4 hours - Group 3 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 17668 | Peak area | Homocysteine Treated-2 hours - Group 2 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 18224 | Peak area | Homocysteine Treated- 8 hours - Group 4 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 18767 | Peak area | Homocysteine Treated- 24 hours - Group 6 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 19371 | Peak area | Methionine Treated - Group 1 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 19549 | Peak area | Homocysteine Treated- 8 hours - Group 4 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 20262 | Peak area | Homocysteine Treated- 4 hours - Group 3 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 20344 | Peak area | Methionine Treated - Group 1 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 20628 | Peak area | Homocysteine Treated- 12 hours - Group 5 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 21613 | Peak area | Homocysteine Treated- 12 hours - Group 5 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 25295 | Peak area | Methionine Treated - Group 1 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 25999 | Peak area | Methionine Treated - Group 1 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 30941 | Peak area | Homocysteine Treated- 4 hours - Group 3 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 36701 | Peak area | Homocysteine Treated- 8 hours - Group 4 |
MS positive ion mode | pyrazine 2,5-dihydroxy NIST | 45304 | Peak area | Homocysteine Treated- 8 hours - Group 4 |